Eastman Chemical Directors Buy Shares, ETF Holds $10.3M Position
Written by Emily J. Thompson, Senior Investment Analyst
Source: NASDAQ.COM
- Insider Buying Trend: Eastman Chemical has seen 11 directors and officers purchase shares in the past six months, indicating strong internal confidence in the company's future, which may enhance investor trust.
- ETF Holdings Analysis: Eastman Chemical comprises 4.65% of the First Trust Materials AlphaDEX Fund, with a total holding value of $10,346,120, making it the fifth-largest position, reflecting market recognition of its growth potential.
- FMC Company Activity: FMC, the 30th largest holding in the ETF, recently had 2 directors and officers file Form 4s indicating purchases, suggesting optimism among insiders about the company's future performance, which could attract more investor interest.
- ETF Asset Allocation: FMC's holding value in the ETF is $2,247,500, representing approximately 1.01% of total assets, showcasing the ETF's diversified investment strategy within the materials sector.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like EMN with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on EMN
Wall Street analysts forecast EMN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EMN is 72.00 USD with a low forecast of 68.00 USD and a high forecast of 74.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
9 Analyst Rating
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 69.030
Low
68.00
Averages
72.00
High
74.00
Current: 69.030
Low
68.00
Averages
72.00
High
74.00
About EMN
Eastman Chemical Company is a global specialty materials company that produces a range of products found in items people use every day. Its segments include Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma, and consumables end-markets. AFP segment manufactures materials for products in food, feed, and agriculture; transportation; water treatment and energy; personal care and wellness; building and construction; consumables, and durables and electronics end-markets. The CI segment sells intermediates for end-markets, such as industrial chemicals and processing, building and construction, health and wellness, and food and feed. Its Fibers segment manufactures and sells acetate tow and triacetin plasticizers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Eastman Chemical Set to Report Q4 Earnings
- Earnings Announcement Date: Eastman Chemical (EMN) is set to release its Q4 earnings on January 29th after market close, with a consensus EPS estimate of $0.72, reflecting a significant year-over-year decline of 61.5%, indicating substantial pressure on profitability.
- Revenue Expectations Decline: The anticipated revenue for Q4 is $2.02 billion, down 10.2% year-over-year, which highlights the negative impact of weak market demand on the company's performance and may lead to decreased investor confidence.
- Historical Performance Review: Over the past two years, Eastman has beaten EPS estimates 75% of the time but only 50% for revenue, indicating volatility in earnings that could affect future investment decisions.
- Revised Expectations: In the last three months, there have been no upward revisions to EPS estimates, with 14 downward adjustments, and similarly, revenue estimates saw no upward revisions and 11 downward adjustments, reflecting a weakening market outlook for the company.
Continue Reading
Eastman Chemical Q4 Revenue Misses Estimates, Shares Drop
- Revenue Decline: Eastman Chemical reported fourth-quarter revenue of $1.97 billion, down from the previous year and below analysts' expectations of $2.02 billion, resulting in a 2.2% drop in after-hours trading due to lower volumes across multiple end markets.
- Earnings Performance: Although adjusted earnings per share were $0.75, exceeding the consensus estimate of $0.72, net income was still impacted by overall revenue decline, highlighting the challenges the company faces in the current economic environment.
- Market Pressures: Sales fell across all major segments, particularly in chemical intermediates and fibers, primarily due to customer inventory destocking and competitive pressures in global commodity markets, exacerbating the decline in performance.
- Future Outlook: Eastman anticipates earnings improvement in 2026 driven by deeper cost reductions and higher utilization rates, although the company refrained from providing a full-year adjusted earnings forecast due to macroeconomic uncertainties.
Continue Reading